These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16202384)

  • 21. Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver.
    Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Gorski J
    J Physiol Pharmacol; 2009 Mar; 60(1):99-106. PubMed ID: 19439812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism.
    Xu C; Wang LL; Liu HY; Zhou XB; Cao YL; Li S
    Acta Pharmacol Sin; 2006 Feb; 27(2):223-8. PubMed ID: 16412273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of peroxisome proliferator-activated receptor alpha activation on leukotriene B4 metabolism in isolated rat hepatocytes.
    Fiedler J; Simon FR; Iwahashi M; Murphy RC
    J Pharmacol Exp Ther; 2001 Nov; 299(2):691-7. PubMed ID: 11602682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of novel and selective peroxisome proliferator-activated receptor alpha agonists with robust hypolipidemic activity in vivo.
    Kane CD; Stevens KA; Fischer JE; Haghpassand M; Royer LJ; Aldinger C; Landschulz KT; Zagouras P; Bagley SW; Hada W; Dullea R; Hayward CM; Francone OL
    Mol Pharmacol; 2009 Feb; 75(2):296-306. PubMed ID: 18971326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kupffer cells suppress perfluorononanoic acid-induced hepatic peroxisome proliferator-activated receptor α expression by releasing cytokines.
    Fang X; Zou S; Zhao Y; Cui R; Zhang W; Hu J; Dai J
    Arch Toxicol; 2012 Oct; 86(10):1515-25. PubMed ID: 22648072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of peroxisome proliferator-activated receptor alpha in rat spinal cord after peripheral noxious stimulation.
    Benani A; Heurtaux T; Netter P; Minn A
    Neurosci Lett; 2004 Oct; 369(1):59-63. PubMed ID: 15380308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist.
    Chen X; Matthews J; Zhou L; Pelton P; Liang Y; Xu J; Yang M; Cryan E; Rybczynski P; Demarest K
    Metabolism; 2008 Nov; 57(11):1516-25. PubMed ID: 18940388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways.
    Goto T; Kim YI; Funakoshi K; Teraminami A; Uemura T; Hirai S; Lee JY; Makishima M; Nakata R; Inoue H; Senju H; Matsunaga M; Horio F; Takahashi N; Kawada T
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E1022-32. PubMed ID: 21862726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma mannose-binding lectin is stimulated by PPARα in humans.
    Rakhshandehroo M; Stienstra R; de Wit NJ; Bragt MC; Haluzik M; Mensink RP; Müller M; Kersten S
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E595-602. PubMed ID: 22215653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catalposide is a natural agonistic ligand of peroxisome proliferator-activated receptor-α.
    Lee JH; Jun HJ; Hoang MH; Jia Y; Han XH; Lee DH; Lee HJ; Hwang BY; Lee SJ
    Biochem Biophys Res Commun; 2012 Jun; 422(4):568-72. PubMed ID: 22583896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Euchresta horsfieldii Benn. activates peroxisome proliferator-activated receptor α and regulates expression of genes involved in fatty acid metabolism in human HepG2 cells.
    Kim JH; Kim D; Kim J; Hwang JK
    J Ethnopharmacol; 2011 Jan; 133(1):244-7. PubMed ID: 20920566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-6 cooperates with peroxisome proliferator-activated receptor-α-ligands to induce liver fatty acid binding protein (LFABP) up-regulation.
    Vida M; Serrano A; Romero-Cuevas M; Pavón FJ; González-Rodriguez A; Gavito AL; Cuesta AL; Valverde AM; Rodríguez de Fonseca F; Baixeras E
    Liver Int; 2013 Aug; 33(7):1019-28. PubMed ID: 23534555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver.
    Oishi K; Uchida D; Ishida N
    FEBS Lett; 2008 Oct; 582(25-26):3639-42. PubMed ID: 18840432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPARalpha is a key regulator of hepatic FGF21.
    Lundåsen T; Hunt MC; Nilsson LM; Sanyal S; Angelin B; Alexson SE; Rudling M
    Biochem Biophys Res Commun; 2007 Aug; 360(2):437-40. PubMed ID: 17601491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical mechanism of insulin sensitization, lipid modulation and anti-atherogenic potential of PPAR alpha/gamma dual agonist: Ragaglitazar.
    Sharma S; Sowjanya A; Kumari M; Suryaprakash R; Cynthia G; Suresh J; Chakrabarti R
    Life Sci; 2006 Dec; 80(3):235-44. PubMed ID: 17014868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of the human PDZK1 expression by peroxisome proliferator-activated receptor alpha.
    Tachibana K; Anzai N; Ueda C; Katayama T; Yamasaki D; Kirino T; Takahashi R; Ishimoto K; Komori H; Tanaka T; Hamakubo T; Ueda Y; Arai H; Sakai J; Kodama T; Doi T
    FEBS Lett; 2008 Nov; 582(28):3884-8. PubMed ID: 18955051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Phytol-Enriched Diet Activates PPAR-α in the Liver and Brown Adipose Tissue to Ameliorate Obesity-Induced Metabolic Abnormalities.
    An JY; Jheng HF; Nagai H; Sanada K; Takahashi H; Iwase M; Watanabe N; Kim YI; Teraminami A; Takahashi N; Nakata R; Inoue H; Seno S; Mastuda H; Kawada T; Goto T
    Mol Nutr Food Res; 2018 Mar; 62(6):e1700688. PubMed ID: 29377597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thioredoxin-1 and its natural inhibitor, vitamin D3 up-regulated protein 1, are differentially regulated by PPARalpha in human macrophages.
    Billiet L; Furman C; Cuaz-Pérolin C; Paumelle R; Raymondjean M; Simmet T; Rouis M
    J Mol Biol; 2008 Dec; 384(3):564-76. PubMed ID: 18848838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly sensitive upregulation of apolipoprotein A-IV by peroxisome proliferator-activated receptor alpha (PPARalpha) agonist in human hepatoma cells.
    Nagasawa M; Akasaka Y; Ide T; Hara T; Kobayashi N; Utsumi M; Murakami K
    Biochem Pharmacol; 2007 Dec; 74(12):1738-46. PubMed ID: 17904533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.